lobbying_activities: 3491845
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3491845 | cf034883-9666-4315-b134-ea79810fbcef | Q4 | TIBER CREEK GROUP | 20744 | JAZZ PHARMACEUTICALS | 2025 | fourth_quarter | MED | Issues related to cannabis research; Issues related to the FDA; Issues related to cannabis research at Health and Human Services. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2026-01-17T14:01:32-05:00 |